Vivo Capital, LLC Tricida, Inc. Transaction History

Vivo Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.19 - $9.56 $703,345 - $1.6 Million	-167,863 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.56 - $4.64 $24,564 - $32,015	-6,900 Reduced 3.95%	167,863 $779,000
Q3 2020 Nov 13, 2020	SELL	$8.56 - $26.93 $8 - $26	-1 Reduced -0.0%	174,763 $1.58 Million
Q2 2020 Aug 14, 2020	SELL	$21.21 - $31.55 $7.41 Million - $11 Million	-349,526 Reduced 66.67%	174,764 $4.8 Million
Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $9.66 Million - $19.9 Million	524,290 New	524,290 $11.5 Million
Q3 2019 Nov 13, 2019	SELL	$29.87 - $42.22 $42.6 Million - $60.1 Million	-1,424,525 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$31.16 - $39.46 $20 Million - $25.4 Million	643,340 Added 82.35%	1,424,525 $56.2 Million
Q4 2018 Feb 13, 2019	SELL	$23.57 - $32.33 $4.96 Million - $6.81 Million	-210,526 Reduced 21.23%	781,185 $18.4 Million
Q2 2018 Aug 10, 2018	BUY	$26.0 - $29.9 $25.8 Million - $29.7 Million	991,711 New	991,711 $29.7 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.